- In the
management of Parkinson's disease, due to the
chronic nature of Parkinson's
disease (PD), a broad-based
program is
needed that
includes patient...
- Long-term
physiotherapy (>6 months) has been
shown to
reduce the need for
antiparkinsonian medication in
patients with Parkinson's Disease. Specifically, multidisciplinary...
-
Hypokinesia and rigidity,
especially in
juvenile cases, can be
treated with
antiparkinsonian drugs, and
myoclonic hyperkinesia can be
treated with
valproic acid...
- that memantine,
along with amantadine, has been
widely used as an
antiparkinsonian agent since at
least 1994.
Although amantadine and
memantine have fairly...
-
reuptake inhibitor activity Budipine t-Bu Ph H Ph
Antiparkinsonian agent Prodipine iPr Ph H Ph
Antiparkinsonian agent Ketobemidone Me 3-HO–Ph H –COEt Opioid...
-
disease for just a
short period of time.
Clinical drugs used as an
antiparkinsonian agent such as
Trihexyphenidyl are
known to
create tactile hallucinations...
-
Piribedil is an
antiparkinsonian agent and
piperazine derivative which acts as a D2 and D3
receptor agonist. It also has α2-adrenergic
antagonist properties...
-
Levodopa was
first synthesized and
isolated in the
early 1910s. The
antiparkinsonian effects of
levodopa were
discovered in the 1950s and 1960s. Following...
-
Tropatepine (brand name Lepticur) is an
anticholinergic used as an
antiparkinsonian agent.
Tropatepine can be
synthesized from 3-chlorotropane (1). A Grignard...
- C. G.; Klawans, H. L.; Thiessen, B. (1989). "Hyper****uality with
antiparkinsonian therapy".
Clinical Neuropharmacology. 12 (5): 375–383. doi:10...
